Jon Kindblom

Ryhov Hospital Jönköping

Papers

1

Total Citations

33

H-Index

1

About

Jon Kindblom is a leading clinical researcher in prostate cancer outcomes, with a focus on patient-reported side effects following curative treatments. His work centers on understanding the real-world impact of radical prostatectomy and radiotherapy on patients' quality of life. Kindblom's major contribution is his 2024 nationwide, register-based study, which provides crucial, population-level data on functional and psychological side effects—including urinary symptoms, bowel disturbances, and erectile dysfunction—one year after treatment. This research addresses a critical gap in the literature by offering unselected, contemporary evidence from a large cohort. With 33 citations in its first year, the study has quickly become a key reference for clinicians and patients weighing treatment decisions. Kindblom’s work is notable for its rigorous methodology and its emphasis on patient-reported outcomes, ensuring that the patient voice shapes clinical understanding. His findings are instrumental in improving shared decision-making and post-treatment care for men with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study
33 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Ryhov Hospital Jönköping

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago